Skye Bioscience, Inc. (SKYE)
0.6248
0.00 (0.00%)
USD |
NASDAQ |
Mar 25, 16:00
0.62
0.00 (0.00%)
Pre-Market: 20:00
Skye Bioscience EPS Diluted (Quarterly) : -0.364 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | -1.203 |
| Merck & Co., Inc. | 1.191 |
| SIGA Technologies, Inc. | -0.0758 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.44M |
| Total Expenses (Quarterly) | 14.44M |
| Enterprise Value | -4.608M |
| Earnings Yield | -225.7% |
| Normalized Earnings Yield | -225.67 |